The comparison of ECG changes of ondansetron and dexamethasone in cochlear implantatio
Phase 2
- Conditions
- long QT syndrom.Other specified conduction disorders
- Registration Number
- IRCT2016122031487N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients aged 6 months to 18 years candidate for cochlear implantation.
Exclusion criteria: Known case of jervell lange nielson syndrome; patients with any cardiac disease; ECG abnormalities; electrolyte abnormalities; usage of drugs which prolong the QT interval and family history of QT prolongation.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prolonged QT interval. Timepoint: 5 and 15 minutes after drug administrationd. Method of measurement: ECG monitoring and calculated by the cardiologist.
- Secondary Outcome Measures
Name Time Method Vomit. Timepoint: After the surgery. Method of measurement: inspection.;Nausea. Timepoint: After the surgery. Method of measurement: inspection.;Prolonged Tp-e interval. Timepoint: 5 and 15 minutes after drug administration. Method of measurement: ECG monitoring and calculated by the cardiologist.